Genome editing of CCR5 by AsCpf1 renders CD4+T cells resistance to HIV-1 infection
Open Access
- 8 July 2020
- journal article
- research article
- Published by Springer Nature in Cell & Bioscience
- Vol. 10 (1) , 1-13
Abstract
The chemokine receptor CCR5 is one of the co-receptor of HIV-1 infection. People with homozygous CCR5Δ32 deletion resist HIV-1 infection, which makes the CCR5 an important target for HIV-1 gene therapy. Although the CRISPR/Cas9 has ever been used for HIV-1 study, the newly developed CRISPR/AsCpf1 has never been utilized in HIV-1 co-receptor disruption. The CRISPR/Cpf1 system shows many advantages over CRISPR/Cas9, such as lower off-target, small size of nuclease, easy sgRNA design for multiplex gene editing, etc. Therefore, the CRISPR/Cpf1 mediated gene editing will confer a more specific and safe strategy in HIV-1 co-receptor disruption. Here, we demonstrated that CRISPR/AsCpf1 could ablate the main co-receptor of HIV-1 infection-CCR5 efficiently with two screened sgRNAs via different delivery strategies (lentivirus, adenovirus). The edited cells resisted R5-tropic HIV-1 infection but not X4-tropic HIV-1 infection compared with the control group in different cell types of HIV-1 study (TZM.bl, SupT1-R5, Primary CD4+T cells). Meanwhile, the edited cells exhibited selective advantage over unedited cells while under the pressure of R5-tropic HIV-1. Furthermore, we clarified that the predicted off-target sites of selected sgRNAs were very limited, which is much less than regular using sgRNAs for CRISPR/Cas9, and no evident off-target was observed. We also showed that the disruption of CCR5 by CRISPR/AsCpf1 took no effects on cell proliferation and apoptosis. Our study provides a basis for a possible application of CCR5-targeting gene editing by CRISPR/AsCpf1 with high specific sgRNAs against HIV-1 infection.Keywords
Funding Information
- China National Special Research Program of Synthetic Biology (2018YFA0902702)
- Shenzhen`s Health and Family Planning Commission Program of Clinic Research (SZLY2018020, SZLY2017008)
This publication has 35 references indexed in Scilit:
- Past, present and future: 30 years of HIV researchNature Reviews Microbiology, 2013
- Developing strategies for HIV-1 eradicationTrends in Immunology, 2012
- Evidence for the cure of HIV infection by CCR5Δ32/Δ32 stem cell transplantationBlood, 2011
- The Challenge of Finding a Cure for HIV InfectionScience, 2009
- Long-Term Control of HIV byCCR5Delta32/Delta32 Stem-Cell TransplantationNew England Journal of Medicine, 2009
- HIV Entry and Its InhibitionCell, 1998
- Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural GeneScience, 1996
- Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor geneNature, 1996
- Homozygous Defect in HIV-1 Coreceptor Accounts for Resistance of Some Multiply-Exposed Individuals to HIV-1 InfectionCell, 1996
- Identification of a major co-receptor for primary isolates of HIV-1Nature, 1996